» Authors » D A Margolis

D A Margolis

Explore the profile of D A Margolis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 202
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wohl D, Bhatti L, Small C, Edelstein H, Zhao H, Margolis D, et al.
HIV Med . 2015 Jul; 17(2):106-17. PMID: 26176344
Objectives: HIV treatment guidelines endorse switching or simplification of antiretroviral therapy in therapy-experienced patients with suppressed viraemia; ritonavir discontinuation may also enhance tolerability and reduce long-term adverse events (AEs). This...
2.
Zhu F, Ramadan G, Davies B, Margolis D, Keever-Taylor C
Clin Exp Immunol . 2007 Nov; 151(2):284-96. PMID: 18005260
Adoptive immunotherapy with in vitro expanded antigen-specific cytotoxic T lymphocytes (CTLs) may be an effective approach to prevent, or even treat, Aspergillus (Asp) infections. Such lines can be generated using...
3.
Talano J, Casper J, Camitta B, Keever-Taylor C, Murray K, Eapen M, et al.
Bone Marrow Transplant . 2005 Nov; 37(2):135-41. PMID: 16273115
Children with Philadelphia chromosome positive (Ph+) acute lymphocytic leukemia (ALL) have only a 20% event-free survival when treated with chemotherapy alone. Bone marrow transplant (BMT) for patients with matched siblings...
4.
Whelan H, Smits Jr R, Buchman E, Whelan N, Turner S, Margolis D, et al.
J Clin Laser Med Surg . 2002 Jan; 19(6):305-14. PMID: 11776448
Objective: The purpose of this study was to assess the effects of hyperbaric oxygen (HBO) and near-infrared light therapy on wound healing. Background Data: Light-emitting diodes (LED), originally developed for...
5.
Keever-Taylor C, Bredeson C, Loberiza F, Casper J, Lawton C, Rizzo D, et al.
Biol Blood Marrow Transplant . 2002 Jan; 7(11):620-30. PMID: 11760150
Multivariate analysis was performed to determine the independent factors affecting the risk of acute GVHD (aGVHD) grades II to IV and extensive chronic GVHD (cGVHD) and the rate of survival...
6.
Keever-Taylor C, Klein J, Eastwood D, Bredeson C, Margolis D, BURNS W, et al.
Bone Marrow Transplant . 2001 Jul; 27(8):791-800. PMID: 11477435
We have performed univariate and multivariate analysis to determine the factors that affect the kinetics of neutrophil and platelet recovery in 546 recipients of T cell-depleted (TCD) marrow allografts. All...
7.
Epperson D, Margolis D, McOlash L, Janczak T, Barrett A
Br J Haematol . 2001 Jul; 114(1):57-62. PMID: 11472345
We studied oligoclonal T-cell expansions of 24 T-cell receptor (TCR) V beta families in normal donor lymphocytes stimulated with patient's cells and in recipient blood after transplant, using a polymerase...
8.
Strasser S, Shulman H, Flowers M, Reddy R, Margolis D, Prumbaum M, et al.
Hepatology . 2000 Nov; 32(6):1265-71. PMID: 11093733
Chronic graft-versus-host disease (GVHD) of the liver usually presents as an indolent cholestatic disease in patients with skin, mouth, and eye involvement. We observed 14 patients in whom chronic GVHD...
9.
Margolis D, Casper J, Segura A, Janczak T, McOlash L, Fisher B, et al.
Biol Blood Marrow Transplant . 2000 Aug; 6(4):408-15. PMID: 10917576
Data from animal models have shown that hepatic graft-versus-host disease (GVHD) may be mediated by donor T cells interacting with liver adhesion molecules, other minor histocompatibility antigens, or both. We...
10.
Margolis D, Casper J
Semin Hematol . 2000 Feb; 37(1):43-55. PMID: 10676910
Bone marrow transplantation (BMT) from a human leukocyte antigen (HLA)-matched sibling is the treatment of choice in children and young adults with severe aplastic anemia (SAA). However, because only 30%...